Hexavalent vaccines

In December 2023, Gavi opened a funding window for eligible countries to switch from pentavalent to hexavalent vaccine, including assistance in assessing financial, logistical, and programmatic implications to determine suitability for their specific contexts. Operational support is also available to facilitate the introduction of the hexavalent vaccine into national immunization programs. ^{Go to footnote 11, Go to footnote 22}